Sage Journals: Discover world-class research

Abstract

Introduction:

Stroke is a leading cause of death and disability. The European Stroke Organization (ESO) developed Stroke Unit certification criteria to standardize and improve stroke care quality. This study evaluates the impact of implementing these criteria on outcomes for acute ischemic stroke patients treated with intravenous thrombolysis (IV alteplase) in an Emergency Hospital in Bucharest, Romania.

Methods:

Our retrospective observational study compared outcomes before (2017–2020) and after (2021–2024) implementation of ESO Stroke Unit certification protocols. Data from 568 patients receiving IV alteplase were analyzed. Our analysis included in-hospital mortality, modified Rankin Scale (mRS) and NIH Stroke Scale (NIHSS) at discharge, NIHSS shift, and key time metrics (door-to-CT, neuro-to-needle, door-to-needle).

Results:

Post-intervention, the annual IV alteplase rate increased significantly (15.47% vs 4.51%, p < 0.001). Time metrics improved, with reductions in door-to-CT (20.41 min vs 49.45 min, p < 0.001), neuro-to-needle (36.43 min vs 63.28 min, p < 0.001) and door-to-needle times (44.64 min vs 73.07 min, p < 0.001). Favorable outcome (mRS 0–1) improved (44.8% vs 33.2%, aOR = 2.33, p < 0.001), and in-hospital mortality decreased (7.3% vs 12.5%, aOR = 0.48, p = 0.02). Symptomatic hemorrhagic transformation also decreased (3.1% vs 7.6%, aOR = 0.31, p = 0.02).

Discussion:

Implementing ESO Stroke Unit certification criteria was associated with significant improvements in thrombolysis rates, key time metrics, and patient outcomes.

Conclusions:

ESO Stroke Unit certification may lead to improved stroke care and patient outcomes, particularly in emerging healthcare systems.

Graphical abstract

Keywords

Stroke ESO stroke unit ESO certification IV tPA

Get full access to this article

View all access options for this article.

References

Wang

Zhang

, et al. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 2023; 54: 1330–1339.

Katan

Luft

Global burden of stroke. Semin Neurol 2018; 38: 208–211.

Prabhakaran

Ruff

Bernstein

RA.

Acute stroke intervention: a systematic review. JAMA 2015; 313: 1451–1462.

Feigin

Brainin

Norrving

, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 2022; 17: 18–29.

Ringelstein

Chamorro

Kaste

, et al. European stroke organisation recommendations to establish a stroke unit and stroke center. Stroke 2013; 44: 828–840.

Waje-Andreassen

Nabavi

Engelter

, et al. European Stroke Organisation certification of stroke units and stroke centres. Eur Stroke J 2018; 3: 220–226.

Dirks

Niessen

van Wijngaarden

, et al. Promoting thrombolysis in acute ischemic stroke. Stroke 2011; 42: 1325–1330.

Alberts

, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283(23): 3102–3109.

Pross

Berger

Siegel

, et al. Stroke units, certification, and outcomes in German hospitals: a longitudinal study of patient-based 30-day mortality for 2006-2014. BMC Health Serv Res 2018; 18: 880.

10.

Chen

Lei

, et al. Certification of stroke centers at primary hospitals and the improvement of thrombolysis n South China during 2020–2022. Eur Stroke J 2024; 9: 477–485.

11.

Man

Cox

Patel

, et al. Differences in acute ischemic stroke quality of care and outcomes by Primary Stroke Center Certification Organization. Stroke 2017; 48: 412–419.

12.

Reeves

Grau-Sepulveda

Fonarow

, et al. Are quality improvements in the get with the guidelines-stroke program related to better care or better data documentation? Circ Cardiovasc Qual Outcomes 2011; 4: 503–511.

13.

Lindsay

Norrving

Furie

, et al., On Behalf of the Global Stroke Quality and Guidelines Advisory Committee, the Global Stroke Guidelines Working Group, and the Global Stroke Quality Working Group. Global Stroke Guidelines and Action Plan: A Road Map for Quality Stroke Care RoAdMAp IMpleMentAtIon GuIde On Behalf of the Global Stroke Quality and Guidelines Advisory Committee, the Global Stroke Guidelines Working Group, and the Global Stroke Quality Working Group. World Stroke Organization, 2016.

14.

Fonarow

Liang

Smith

, et al. Comparison of performance achievement award recognition with primary stroke center certification for acute ischemic stroke care. J Am Heart Assoc 2013; 2: e000451.

15.

Arnold

Engelter

Lyrer

, et al. Certification of stroke centre and stroke units in Switzerland. Transl Neurosci Clin 2018; 2: 2514183X1773840.

16.

Meretoja

Roine

Kaste

, et al. Effectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from Finland. Stroke 2010; 41: 1102–1107.

17.

Gorelick

PB.

Primary and comprehensive stroke centers: history, value and certification criteria. Stroke 2013; 15: 78–89.

18.

Leys

Ringelstein

Kaste

, et al. The main components of stroke unit care: Results of a European expert survey. Cerebrovasc Dis 2007; 23: 344–352.

19.

Weisscher

Vermeulen

Roos

, et al. What should be defined as good outcome in stroke trials: a modified Rankin score of 0-1 or 0-2? J Neurol 2008; 255: 867–874.

20.

Hacke

Kaste

Bluhmki

, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317–1329.

21.

Mustanoja

Meretoja

Putaala

, et al. Outcome by stroke etiology in patients receiving thrombolytic treatment descriptive subtype analysis. Stroke 2011; 42: 102–106.

22.

Förster

Gass

Kern

, et al. Gender differences in acute ischemic stroke etiology, stroke patterns and response to thrombolysis. Stroke 2009; 40: 2428–2432.

23.

Jones

Sen

Lakshminarayan

, et al. Poststroke outcomes vary by pathogenic stroke subtype in the atherosclerosis risk in communities study. Stroke 2013; 44: 2307–2310.

24.

Prabhakaran

McNulty

O’Neill

, et al. Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke 2012; 43: 875–877.

25.

Kuhrij

Marang-van de Mheen

van den Berg-Vos

, et al. Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit. BMC Neurol 2019; 19: 265.

26.

Xian

Lytle

, et al. Use of strategies to improve Door-to-Needle times with tissue-type plasminogen activator in acute ischemic stroke in clinical practice: findings from target: stroke. Circ Cardiovasc Qual Outcomes 2017; 10: e003227. DOI: 10.1161/CIRCOUTCOMES.116.003227.

27.

Reeves

Parker

Fonarow

, et al. Development of stroke performance measures: definitions, methods, and current measures. 2010; 41: 1573–578. DOI: 10.1161/STROKEAHA.109.577171.

28.

Xian

Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA 2011; 305: 373–380.

29.

Fonarow

Zhao

Smith

, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014; 311: 1632–1640.

30.

Abilleira

Ribera

Permanyer-Miralda

, et al. Noncompliance with certain quality indicators is associated with risk-adjusted mortality after stroke. Stroke 2012; 43: 1094–1100.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.02 MB

0.00 MB